Table 4.

HPV status in 2850 cervical cancer cases from a nationwide audit procedure, listed by type (single infections only), multiple, negative and not tested respectively, as defined by PCR, and/or RNA sequencing results.

HPV type	No of cases (n)	% of valid results % (95% CI)	% among any HPV infections % (95% CI)
16	1401	49.16 (47.31–51.01)	53.37 (51.44–55.29)
18	460	16.14 (14.81–17.54)	17.52 (16.09–19.03)
45	192	6.74 (5.84–7.72)	7.31 (6.35–8.38)
33	105	3.68 (3.02–4.44)	4.00 (3.28–4.82)
31	88	3.09 (2.48–3.79)	3.35 (2.70–4.11)
52	41	1.44 (1.03–1.95)	1.56 (1.12–2.11)
39	30	1.05 (0.71–1.50)	1.14 (0.77–1.63)
56	29	1.02 (0.68–1.46)	1.11 (0.74–1.58)
73	28	0.98 (0.65–1.42)	1.07 (0.71–1.54)
58	26	0.91 (0.60–1.33)	0.99 (0.65–1.45)
35	22	0.77 (0.48–1.17)	0.84 (0.53–1.27)
70	23	0.81 (0.51–1.21)	0.88 (0.56–1.31)
59	18	0.63 (0.38–1.00)	0.69 (0.41–1.08)
6	11	0.39 (0.19–0.69)	0.42 (0.21–0.75)
53	9	0.32 (0.14–0.60)	0.34 (0.16–0.65)
66	9	0.32 (0.14–0.60)	0.34 (0.16–0.65)
42	8	0.28 (0.12–0.55)	0.31 (0.13–0.60)
68	7	0.25 (0.10–0.51)	0.27 (0.11–0.55)
11	5	0.18 (0.06–0.41)	0.19 (0.06–0.44)
67	5	0.18 (0.06–0.41)	0.19 (0.06–0.44)
51	4	0.14 (0.04–0.36)	0.15 (0.04–0.39)
34	3	0.11 (0.02–0.31)	0.11 (0.02–0.33)
90	2	0.07 (0.01–0.25)	0.08 (0.01–0.28)
69	1	0.04 (0.001–0.20)	0.04 (0.001–0.21)
32	1	0.04 (0.001–0.20)	0.04 (0.001–0.21)
38	1	0.04 (0.001–0.20)	0.04 (0.001–0.21)
54	1	0.04 (0.001–0.20)	0.04 (0.001–0.21)
82	1	0.04 (0.001–0.20)	0.04 (0.001–0.21)
87	1	0.04 (0.001–0.20)	0.04 (0.001–0.21)
202	1	0.04 (0.001–0.20)	0.04 (0.001–0.21)
Multiple HPV infection	92	3.23 (2.61–3.94)	3.51 (2.83–4.28)
Any HPV infection	2625	92.11 (91.05–93.07)	100
HPV negative	223	7.83 (6.87–8.87)	NA
Specimen not tested	2	0.07 (0.01–0.25)	NA
Total valid results	2850	100	NA